Exclusive

Publication

Byline

US Patent Issued to Janssen Biotech on June 2 for "CALR and JAK2 T-cell receptors" (Pennsylvania, New Jersey Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,643,931, issued on June 2, was assigned to Janssen Biotech Inc. (Horsham, Pa.). "CALR and JAK2 T-cell receptors" was invented by Rebecca Hanson ... Read More


US Patent Issued to UCL Business on June 2 for "Engineered regulatory T cell" (British Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,643,932, issued on June 2, was assigned to UCL Business Ltd (London). "Engineered regulatory T cell" was invented by Hans Stauss (London), Shary... Read More


US Patent Issued to Simcere Innovation on June 2 for "Armed dual CAR-T compositions and methods for cancer immunotherapy" (Massachusetts Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,643,933, issued on June 2, was assigned to Simcere Innovation Inc. (Cambridge, Mass.). "Armed dual CAR-T compositions and methods for cancer imm... Read More


US Patent Issued to King's College London on June 2 for "Proinsulin peptides for Type 1 Diabetes" (British Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,643,934, issued on June 2, was assigned to King's College London (Greater London, Great Britain). "Proinsulin peptides for Type 1 Diabetes" was ... Read More


US Patent Issued to ST. JUDE CHILDREN'S RESEARCH HOSPITAL on June 2 for "Chimeric GMCSF-IL18 receptor" (Dutch, American Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,643,936, issued on June 2, was assigned to ST. JUDE CHILDREN'S RESEARCH HOSPITAL INC. (Memphis, Tenn.). "Chimeric GMCSF-IL18 receptor" was inven... Read More


US Patent Issued to Chugai Seiyaku on June 2 for "Fc region variant" (Japanese Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,643,937, issued on June 2, was assigned to Chugai Seiyaku K.K. (Tokyo). "Fc region variant" was invented by Futa Mimoto (Shizuoka, Japan), Hitos... Read More


US Patent Issued to Amgen on June 2 for "Fc-containing molecules exhibiting predictable, consistent, and reproducible glycoform profiles" (Washington, California Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,643,938, issued on June 2, was assigned to Amgen Inc. (Thousand Oaks, Calif.). "Fc-containing molecules exhibiting predictable, consistent, and ... Read More


US Patent Issued to The Council of the Queensland Institute of Medical Research on June 2 for "Antibody to Epstein Barr virus and uses thereof" (Australian Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,643,939, issued on June 2, was assigned to The Council of the Queensland Institute of Medical Research (Herston, Australia). "Antibody to Epstei... Read More


US Patent Issued to Universitat zu Koln on June 2 for "Broadly neutralizing antibodies against HIV" (German Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,643,940, issued on June 2, was assigned to Universitat zu Koln (Cologne, Germany). "Broadly neutralizing antibodies against HIV" was invented by... Read More


US Patent Issued to Trellis Bioscience on June 2 for "Therapeutic protein formulations comprising anti-DNABII antibodies and uses thereof" (California Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,643,941, issued on June 2, was assigned to Trellis Bioscience Inc. (Redwood City, Calif.). "Therapeutic protein formulations comprising anti-DNA... Read More